Departmental board
Departmental board - information in accordance with Article 24 of the Internal Regulation No. 15/2023 as amended by Amendment No. 1
The faculty shall establish a departmental board for each course/study programme. If doctoral studies are provided in cooperation with an external education institution, the external education institution shall be represented accordingly in the relevant departmental board.
The departmental board shall consist of a chair and at least four other members. At least one of the members of the departmental board must have the scientific-pedagogical title of professor, the scientific rank of doctor of sciences or must be awarded the scientific qualification degree I. Other members of the departmental board may be
a) university teachers and researchers with the scientific-pedagogical title of associate professor,
b) university teachers and researchers with the academic degree of PhD., scientific rank CSc.,
c) university teachers and researchers with a scientific qualification degree II, or
d) qualified experts in the field who have any of the academic titles, scientific-educational titles or scientific degrees specified above.
The rules governing the establishment of departmental boards shall be governed by an internal regulation of the faculty issued by the dean after it has been approved by the faculty scientific board.
The departmental board shall mainly
a) monitor and assess doctoral studies in the particular field of study,
b) approve topics of dissertation theses,
c) approve the doctoral student's individual study plan,
d) review the negative opinion of the chair of the departmental board on the dissertation thesis,
e) propose to the dean the members of the examination board for the defence of the dissertation thesis and the external examiners of the dissertation thesis, if the proposal is not made by the chair of the departmental board.
The chair of the departmental board shall in particular
a) propose to the dean the chair and members of the admissions board for the entrance examination for doctoral studies,
b) express their opinion on the application for the dissertation examination and confirms the fulfilment of all conditions necessary for conducting the dissertation examination and for submitting the written work for the dissertation examination,
c) comment on a doctoral student's request for permission to defend the dissertation thesis and examine the fulfilment of the content and formal requirements imposed on the dissertation thesis,
d) ask a doctoral student to eliminate any shortcomings in the mandatory particulars of a dissertation thesis or a request for a permission to defend their dissertation thesis,
e) comment on the transfer of credits in the context of the academic mobility of a doctoral student,
f) express their opinion on the recognition of completed subjects in the case of a doctoral degree programme change and in the case of a change in the form of the doctoral studies,
g) propose the chair and members of the examination board to the dean for a dissertation examination,
h) propose an external examiner of a written thesis to the dissertation examination to the dean,
i) propose to the dean external examiners of the dissertation thesis, while the proposal of the external examiners may be based on the proposal of the supervisor,
j) propose the structure of examination board to the dean for the defence of dissertation theses,
k) propose to the dean the appointment of a new supervisor in the event of the premature termination of the function of the original supervisor of a doctoral student,
l) submit a proposal for expelling the doctoral student from doctoral studies to the dean.
Departmental Board for Pharmaceutical Chemistry Study Programmes
Composition
(in alphabetical order)
| doc. Mgr. Fils Andriamainty, PhD. – FaF UK Bratislava | member |
| doc. Mgr. Andrea Bilková, PhD. – FaF UK Bratislava | member |
| doc. Ing. Pavel Bobáľ, CSc. – FaF MUNI Brno, ČR | member |
| doc. RNDr. Andrej Boháč, PhD. – Prif UK Bratislava | member |
| prof. RNDr. Jozef Csöllei, CSc. – FaF MUNI Brno, ČR | member |
| Dr. h. c. prof. RNDr. Jozef Čižmárik, PhD. emer. prof. – FaF UK Bratislava | member |
| prof. PharmDr. Martin Doležal, Ph.D. – FaF UK Hradec Králové, ČR | member |
| prof. Ing. Vladimír Frecer, DrSc. – FaF UK Bratislava | member |
| Ing. Ladislav Habala, Dr.rer.nat. – FaF UK Bratislava | member |
| prof. RNDr. Emil Havránek, PhD., emer. prof. – FaF UK Bratislava | member |
| doc. Mgr. Martina Hrčka Dubničková, PhD. – FaF UK Bratislava | secretary |
| prof. PharmDr. Daniela Ježová, DrSc. – BMC SAV, Bratislava | member |
| doc. PharmDr. Peter Křenek, PhD. – FaF UK Bratislava | member |
| prof. Ing. Ján Labuda, DrSc., emer prof. – FCHPT STU, Bratislava | member |
| doc. PharmDr. Miloš Lukáč, PhD. - FaF UK Bratislava | member |
| doc. PharmDr. Ivan Malík, PhD. – FaF UK Bratislava | member |
| doc. PharmDr. Marek Máťuš, PhD. – FaF UK Bratislava | member |
| prof. RNDr. Peter Mikuš, PhD. – FaF UK Bratislava | chairman |
| prof. Ing. Viktor Milata, DrSc. – FCHPT STU, Bratislava | member |
| prof. PharmDr. Pavel Mučaji, PhD. – FaF UK Bratislava | member |
| doc. PharmDr. Marek Obložinský, PhD. – FaF UK Bratislava | member |
| doc. PharmDr. Juraj Piešťanský, PhD. – FaF UK Bratislava | member |
| doc. Ing. Martin Pisárčik, CSc. – FaF UK Bratislava | member |
| prof. Ing. Peter Segľa, DrSc. – FCHPT STU, Bratislava | member |
| prof. RNDr. Petr Solich, CSc. – FaF UK Hradec Králové, ČR | member |
| doc. Ing. Ladislav Štibrányi, CSc. – FCHPT STU, Bratislava | member |
| prof. Ing. Ľubomír Švorc, DrSc. – FCHPT STU, Bratislava | member |
| prof. RNDr. Daniela Uhríková, PhD. – FaF UK Bratislava | member |
| doc. PharmDr. Jindra Valentová, PhD. – FaF UK Bratislava | vice-chairman |
Departmental Board for Pharmaceutical Technology Study Programmes
Composition
(in alphabetical order)
| doc. Mgr. Andrea Bilková, PhD. – FaF UK Bratislava | member |
| Mgr. Mária Klacsová, PhD. – FaF UK Bratislava | secretary |
| PharmDr. Andrej Kováč, Ph.D. – FaF UK Bratislava | member |
| Mgr. Juraj Kronek, PhD. – Ústav polymérov SAV | member |
| doc. PharmDr. Miloš Lukáč, PhD. – FaF UK Bratislava | member |
| PharmDr. Veronika Mikušová, PhD. – FaF UK Bratislava | member |
| doc. PharmDr. Juraj Piešťanský, PhD. – FaF UK Bratislava | member |
| doc. Ing. Martin Pisárčik, CSc. – FaF UK Bratislava | vice-chairman |
| prof. RNDr. Daniela Uhríková, CSc. – FaF UK Bratislava | chairman |
| prof. PharmDr., Mgr. David Vetchý, Ph.D. – FaF MUNI Brno, ČR | member |
Departmental Board for Pharmacognosy Study Programmes
Composition
(in alphabetical order)
| doc. PharmDr. Silvia Bittner Fialová, PhD. – FaF UK, Bratislava | vice-chairman |
| prof. Ing. Lucie Cahlíková, Ph.D. – FaF UK Hradec Králové, ČR | member |
| doc. PharmDr. Szilvia Czigle, PhD. – FaF UK, Bratislava | member |
| Claudio Ferrante, assoc. prof., Ph.D. - University Chieti-Pescara, Taliansko | member |
| doc. Ing. Miroslav Habán, PhD. – FaF UK, Bratislava | member |
| doc. PharmDr. Renata Kubínová, Ph.D. – FaF MUNI Brno, ČR | member |
| prof. PharmDr. Přemysl Mladěnka, Ph.D – FaF UK Hradec Králové, ČR | member |
| prof. Ing. Milan Nagy, CSc. – FaF UK, Bratislava | chairman |
| doc. PharmDr. Marek Obložinský, PhD. – FaF UK, Bratislava | secretary |
| doc. PharmDr. Juraj Piešťanský, PhD. - FaF UK, Bratislava | member |
| prof. PharmDr. Karel Šmejkal, Ph.D. – FaF MUNI Brno, ČR | member |
| prof. MUDr. Martin Wawruch, PhD. – LF UK, Bratislava | member |
Departmental board for Pharmacology Study Programmes
Composition
(in alphabetical order)
| prof. PharmDr. Adriana Duriš Adameová, DrSc. – FaF UK, Bratislava | chairman |
| prof. RNDr. Soňa Fraňová, PhD. – JLF UK, Martin | member |
| prof. PharmDr. Daniela Ježová, DrSc. – BMC SAV, Bratislava | member |
| prof. Ján Klimas, PhD., MPH – FaF UK, Bratislava | member |
| doc. PharmDr. Peter Křenek, PhD. – FaF UK, Bratislava | vice-chairman |
| RNDr. Mojmír Mach, PhD. – CEM SAV, Bratislava | member |
| doc. PharmDr. Marek Máťuš, PhD. – FaF UK, Bratislava | member |
| doc. Mgr. Diana Vavrincová – FaF UK, Bratislava | secretary |
Departmental board for Clinical Pharmacy Study Programmes
Composition
(in alphabetical order)
| doc. PharmDr. Blažena Cagáňová, PhD. – NTCI UN, Bratislava | member |
| prof. PharmDr. Daniela Ježová, DrSc. – BMC SAV, Bratislava | member |
| prof. PharmDr. Ján Klimas, PhD., MPH – FaF UK, Bratislava | chairman |
| doc. PharmDr. Stanislava Kosírová, PhD. – FaF UK, Bratislava | secretary |
| prof. PharmDr. Ján Kyselovič, CSc. – UVLF, Košice | member |
| doc. PharmDr. Daniela Mináriková, MSc., PhD. – FaF UK, Bratislava | member |
| doc. PharmDr. Anna Paul Hrabovská, PhD. – FaF UK, Bratislava | vice-chairman |
| doc. PharmDr. Tomáš Tesař, PhD., MBA, MSc. – FaF UK, Bratislava | member |
Recommendation of the Departmental board for pharmacology
Recommendation for meeting the conditions for submitting a request for permission to defend a dissertation thesis for students of pharmacology study programmes who began their studies in the 2026/2027 academic year:
Members of the Departmental board recommend taking all measures so that the graduating doctoral student, as part of the outputs of scientific creative activity, documents first-author scientific work in journals with IF, effective from 2026/2027. (Source: Minutes from the meeting of the departmental board committee on pharmacology on November 14, 2025.)
Recommendation of the Departmental board for clinical pharmacy
Recommendation for meeting the conditions for submitting a request for permission to defend a dissertation thesis for students of clinical pharmacy study programmes who began their studies in the 2026/2027 academic year:
The Departmental board recommends that a doctoral student in the clinical pharmacy study programme, when submitting a request for permission to defend a dissertation thesis, publish at least one first-author scientific paper in a journal with IF. (Source: Minutes from the meeting of the departmental board committee on clinical pharmacy on December 3, 2025.)